Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics ...Middle East

PR Newswire - News
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Lilly Gateway Labs is a...

    Hence then, the article about rznomics joins lilly gateway labs in san diego to accelerate rna therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

    Read More Details
    Finally We wish PressBee provided you with enough information of ( Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics )

    Apple Storegoogle play

    Last updated :

    Also on site :

    Most viewed in News